2023
Impact of multi-site clinical trial results on clinical practice: Use of risperidone to treat PTSD nationally in the veterans health administration
Rosenheck R, Kurtz S, Anand S, Hau C, Smedberg D, Sicilia R, Pontzer J, Ferguson R. Impact of multi-site clinical trial results on clinical practice: Use of risperidone to treat PTSD nationally in the veterans health administration. Psychiatry Research 2023, 321: 115071. PMID: 36720177, DOI: 10.1016/j.psychres.2023.115071.Peer-Reviewed Original ResearchConceptsClinical practiceNational VHA administrative dataOral second-generation antipsychoticsUse of risperidoneVHA administrative dataSecond-generation antipsychoticsMulti-site clinical trialVeterans Health AdministrationClinical trialsEffectiveness trialHealth AdministrationRisperidoneCooperative StudyYear of publicationAdministrative dataPTSDTrialsYearsAntipsychoticsStudy resultsAdministration
2017
Opioid agonist treatment in the Veterans Health Administration: is health care local?
Peglow S, Petrakis I, Rosenheck R. Opioid agonist treatment in the Veterans Health Administration: is health care local? Journal Of Public Mental Health 2017, 16: 28-36. DOI: 10.1108/jpmh-08-2016-0033.Peer-Reviewed Original ResearchOpioid agonist treatmentOpioid use disorderVeterans Health AdministrationOpioid-related deathsHealth insurance coverageAgonist treatmentHealth AdministrationLocal health system performanceCase identificationHealth systemInsurance coverageVHA administrative dataPublic health challengePublic health systemHealth care systemHealth system performanceNational health care systemUse disordersDrug useMedian incomeSignificant associationHealth challengesCare systemCentralized health systemHealth care